Returns Are Gaining Momentum At Vikas Proppant & Granite (NSE:VIKASPROP)

By
Simply Wall St
Published
November 17, 2021
NSEI:VIKASPROP
Source: Shutterstock

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. With that in mind, we've noticed some promising trends at Vikas Proppant & Granite (NSE:VIKASPROP) so let's look a bit deeper.

Return On Capital Employed (ROCE): What is it?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Vikas Proppant & Granite:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.0013 = ₹2.4m ÷ (₹3.9b - ₹2.0b) (Based on the trailing twelve months to March 2021).

Therefore, Vikas Proppant & Granite has an ROCE of 0.1%. Ultimately, that's a low return and it under-performs the Chemicals industry average of 17%.

See our latest analysis for Vikas Proppant & Granite

roce
NSEI:VIKASPROP Return on Capital Employed November 18th 2021

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you're interested in investigating Vikas Proppant & Granite's past further, check out this free graph of past earnings, revenue and cash flow.

So How Is Vikas Proppant & Granite's ROCE Trending?

Shareholders will be relieved that Vikas Proppant & Granite has broken into profitability. While the business was unprofitable in the past, it's now turned things around and is earning 0.1% on its capital. On top of that, what's interesting is that the amount of capital being employed has remained steady, so the business hasn't needed to put any additional money to work to generate these higher returns. That being said, while an increase in efficiency is no doubt appealing, it'd be helpful to know if the company does have any investment plans going forward. After all, a company can only become a long term multi-bagger if it continually reinvests in itself at high rates of return.

For the record though, there was a noticeable increase in the company's current liabilities over the period, so we would attribute some of the ROCE growth to that. The current liabilities has increased to 51% of total assets, so the business is now more funded by the likes of its suppliers or short-term creditors. Given it's pretty high ratio, we'd remind investors that having current liabilities at those levels can bring about some risks in certain businesses.

The Bottom Line

In summary, we're delighted to see that Vikas Proppant & Granite has been able to increase efficiencies and earn higher rates of return on the same amount of capital. And since the stock has fallen 33% over the last year, there might be an opportunity here. So researching this company further and determining whether or not these trends will continue seems justified.

One more thing to note, we've identified 3 warning signs with Vikas Proppant & Granite and understanding them should be part of your investment process.

While Vikas Proppant & Granite may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.